1Cohn JN,Brisrow MR,Chien KR,et al.Report of the National Heart,Lung,and BLood Institute special emphasis panel on herat failure research.Circulation,1997,95:766.
2Harding SE,Brown LA,Wynne DG,et al.Mechaniams of βadrenoceptor desensitisatioin in the failing human heart.Cardiovase Res,1994,28:1451.
3Kawaguchi H,Kitabatske A.Renin angiotensin system in failing heart J Mol Cell Cardiol,1995,27:201.
4Yokoyama T,Nakano M,Bednarczyk JL,et al.Tumor necrosis factor-a provokes a hypertrophie growth responan in aduk cardiac myoeytes.Circulation.1997,95:1247.
5Koss KL,Kranias EG,Phospholamban:a prominent regulator of myocardial contractility.Cire Res,1996,79:1059.
6Arai M,Sareoplasmie reticulum gene expression in cardiac hypertrophy and beart faihure.Circ Res,1994,74(4):555.
7Mac Lellan WR,Schneider MD,Deathly design:programmed cell death in cardiovascular biology and disease.Cire Res,1997,81:137.
8Remme WJ,The tratment of heart failure:the task force of the working group on heart failure of the European Sociesty of Cardiology.Eur Heart J,1997,18:736.
9Doughty RN,Sharpe N,Bleta-adrenergic blocking agents in the treatment of congestive heart failure:Mechanisms and clinical results.Ann Rev Med 1997,48:103.
